Kura Oncology's stock price fell 18.5% because Johnson & Johnson released data related to a hematologic cancer treatment.

Zhitongcaijing · 2d ago
Kura Oncology's stock price fell 18.5% because Johnson & Johnson released data related to a hematologic cancer treatment.